Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis: a Prospective, Observational Pilot Study
Conditions
Interventions
Tofacitinib 5 MG
Locations
1
China
Second Affiliated Hospital, School of Medicine, Zhejiang University, China
Hangzhou, Zhejiang, China
Start Date
May 1, 2024
Primary Completion Date
June 30, 2025
Completion Date
December 30, 2025
Last Updated
April 1, 2024
NCT06516952
NCT06342713
NCT07247695
NCT07122973
NCT06801626
NCT06503510
Lead Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions